Trinity Biotech reported $19.18M in Operating Expenses for its fiscal quarter ending in September of 2023.

Operating Expenses Change Date
EDAP TMS EUR 23.09M 5.8M Dec/2023
Roche Holding CHF 20.02B 5.04B Jun/2023
Siemens EUR 18.48B 1.89B Sep/2023
Tosoh JPY 235.26B 8.2B Dec/2023
Trinity Biotech USD 19.18M 9.57M Sep/2023